Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients.
作者信息
Sackett J F, Strother C M, Quaglieri C E, Javid M J, Levin A B, Duff T A
出版信息
Radiology. 1977 Jun;123(3):779-82. doi: 10.1148/123.3.779.
PMID:860047
Abstract
Two-hundred-fifteen patients were evaluated with metrizamide, a new water-soluble contrast agent for use in the subarachnoid spaces. Side effects were reported in 67% of these; 39% were moderate or severe. Cervical injections monitored by fluoroscopy provide the most precise positioning of the medium. The benefits of metrizamide use outweigh its risk.
摘要
Zotero 插件